Madrigal Pharmaceuticals (United States)

Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis

Aim: Metabolic dysfunction-associated steatohepatitis (MASH) and steatotic liver disease (MASLD) are progressive liver conditions that can lead to serious long-term outcomes and adverse clinical events. Histologic liver fibrosis is an accepted short-term surrogate end point used...